Cosmos Health Inc. Secures Bond Loan from European Bank

Cosmos Health Inc. (NASDAQ:COSM) has recently announced a significant financial maneuver aimed at bolstering its strategic initiatives. On January 27, 2025, the company’s wholly owned subsidiary, CosmoFarm S.A., finalized an agreement with a European bank to issue a secured bond worth €2,200,000 (approximately $2,293,830).

The purpose behind this financial arrangement is to furnish support for Cosmos Health’s growth objectives and to provide funding for various corporate endeavors, particularly focusing on working capital requirements. This move is anticipated to offer the company a solid financial foundation to pursue its outlined strategic goals effectively.

The secured bond issued by CosmoFarm S.A. is set to be divided into two distinct tranches: Series A Bonds amounting to €700,000 and Series B Bonds totaling €1,500,000. The collateral for this bond will be CosmoFarm’s wholly owned building, ensuring a secure backing for the transaction. The repayment terms for the bond entail ten equal semi-annual installments for Series A Bonds, while Series B Bonds are to be repaid in full upon the bond’s maturity in 2030.

Cosmos Health’s CEO, Greg Siokas, expressed confidence in the implications of this secured bond issuance. Siokas highlighted the company’s ability to leverage its assets effectively and secure non-dilutive capital at competitive terms. This financial move exemplifies the company’s commitment to fortifying its financial position and advancing its strategic initiatives with a view to achieving positive operating cash flow in the future.

About Cosmos Health Inc.
Cosmos Health Inc., founded in Nevada in 2009, is a globally diversified healthcare organization engaged in various segments such as R&D, pharmaceutical manufacturing, distribution, and telehealth services. The company’s portfolio includes proprietary pharmaceutical and nutraceutical brands, with a strong presence in manufacturing pharmaceuticals, food supplements, cosmetics, and medical devices. Operating through subsidiaries in Greece and the UK, Cosmos Health is on a trajectory of expansion across Europe, Asia, and North America.

Forward-Looking Statements
Apart from historical data, the information shared here may contain forward-looking statements. These forward-looking statements involve inherent risks and uncertainties that could impact the company’s future significantly. Readers are advised to refer to the risk factors outlined in the company’s filings with the SEC for a comprehensive overview.

Investor Relations Contact
For further information, please contact BDG Communications at [email protected] or +44 207 0971 653.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cosmos Health’s 8K filing here.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.